Home > Insider Trading > Filing (0001127602-12-032228)

Filing Details

Accession Number:: 0001127602-12-032228
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-11-28 20:16:02
Reporting Period:: 2012-11-26

Filing Date:: 2012-11-28
Accepted Time:: 2012-11-28 20:16:02
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
850693	Allergan Inc	AGN	Pharmaceutical Preparations (2834)	951622442

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1158587	R Michael Gallagher	2525 Dupont Drive Irvine CA 92612		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2012-11-19	47,700	$0.00	47,700	No	5	G	Indirect	By Gallagher Family Trust
Common Stock	Disposition	2012-11-19	47,700	$0.00	17,500	No	5	G	Direct
Common Stock	Disposition	2012-11-20	8,700	$0.00	8,800	No	5	G	Direct
Common Stock	Disposition	2012-11-26	4,700	$91.20	43,000	No	4	S	Indirect	By Gallagher Family Trust
Common Stock	Disposition	2012-11-27	11,802	$91.93	31,198	No	4	S	Indirect	By Gallagher Family Trust
Common Stock	Acquisiton	2012-11-27	5,000	$45.89	13,800	No	4	M	Direct
Common Stock	Acquisiton	2012-11-27	5,000	$36.49	18,800	No	4	M	Direct
Common Stock	Acquisiton	2012-11-27	10,632	$46.66	29,432	No	4	M	Direct
Common Stock	Disposition	2012-11-27	20,632	$92.07	8,800	No	4	S	Direct
Common Stock	Acquisiton	2012-11-28	768	$46.66	9,568	No	4	M	Direct
Common Stock	Acquisiton	2012-11-28	9,000	$51.72	18,568	No	4	M	Direct
Common Stock	Disposition	2012-11-28	9,768	$91.29	8,800	No	4	S	Direct
Common Stock	Disposition	2012-11-28	3,598	$91.68	27,600	No	4	S	Indirect	By Gallagher Family Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	5	G	Indirect	By Gallagher Family Trust
No	5	G	Direct
No	5	G	Direct
No	4	S	Indirect	By Gallagher Family Trust
No	4	S	Indirect	By Gallagher Family Trust
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Indirect	By Gallagher Family Trust

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Nonemployee Director Stock Option (Right to Buy)	Disposition	2012-11-27	5,000	$0.00	5,000	$45.89
Common Stock	Nonemployee Director Stock Option (Right to Buy)	Disposition	2012-11-27	5,000	$0.00	5,000	$36.49
Common Stock	Nonemployee Director Stock Option (Right to Buy)	Disposition	2012-11-27	10,632	$0.00	10,632	$46.66
Common Stock	Nonemployee Director Stock Option (Right to Buy)	Disposition	2012-11-28	768	$0.00	768	$46.66
Common Stock	Nonemployee Director Stock Option (Right to Buy)	Disposition	2012-11-28	9,000	$0.00	9,000	$51.72

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2005-04-28	2014-04-28	No	4	M	Direct
0	2006-04-26	2015-04-26	No	4	M	Direct
768		2019-04-30	No	4	M	Direct
0		2019-04-30	No	4	M	Direct
0	2007-05-02	2016-05-02	No	4	M	Direct

Footnotes

Transfer of 47,700 shares held directly by the reporting person to the Gallagher Family Trust.
Shares held by the Gallagher Family Trust. Reporting Person is trustee of the Gallagher Family Trust.
The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $91.00 to $91.42, inclusive. The reporting person undertakes to provide Allergan, Inc., any security holder of Allergan, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $91.75 to $92.35, inclusive. The reporting person undertakes to provide Allergan, Inc., any security holder of Allergan, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $92.00 to $92.35, inclusive. The reporting person undertakes to provide Allergan, Inc., any security holder of Allergan, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $91.25 to $91.36, inclusive. The reporting person undertakes to provide Allergan, Inc., any security holder of Allergan, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $91.50 to $91.88, inclusive. The reporting person undertakes to provide Allergan, Inc., any security holder of Allergan, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
Option is fully vested and exercisable upon the earlier to occur (i) the first anniversary of the grant date, or (ii) the annual meeting held during such calendar year at which one or more members of the board are standing for re-election following the date of grant.